Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
127.10
-1.67 (-1.29%)
Oct 8, 2025, 3:33 PM EDT
Novartis AG Revenue
Novartis AG had revenue of $14.84B in the quarter ending June 30, 2025, with 15.26% growth. This brings the company's revenue in the last twelve months to $55.19B, up 12.95% year-over-year. In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth.
Revenue (ttm)
55.19B
Revenue Growth
+12.95%
P/S Ratio
4.66
Revenue / Employee
727.25K
Employees
75,883
Market Cap
257.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.72B | 5.06B | 10.85% |
Dec 31, 2023 | 46.66B | 3.20B | 7.36% |
Dec 31, 2022 | 43.46B | -513.00M | -1.17% |
Dec 31, 2021 | 43.97B | -5.92B | -11.87% |
Dec 31, 2020 | 49.90B | 1.22B | 2.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
Nuo Therapeutics | 1.95M |
Novartis AG News
- 1 day ago - Novartis (NVO) Streamlines Operations with Layoffs in the US - GuruFocus
- 2 days ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 2 days ago - 3 Reasons Growth Investors Will Love Novartis (NVS) - Nasdaq
- 2 days ago - Why Novartis (NVS) is a Top Momentum Stock for the Long-Term - Nasdaq
- 2 days ago - NVS Named Top 10 SAFE International Dividend Stock - Nasdaq
- 5 days ago - Novartis: Superstars Entresto And Kisqali Fuel Market Outperformance - Seeking Alpha
- 6 days ago - Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? - Nasdaq
- 7 days ago - Swiss pharma companies eye follow up to Pfizer-US pricing deal, business lobby says - Yahoo